HNRNPA2B1 and liver cancer: Hnrnpa2b1, an N6-methyladenosine (m6a) reader, can recognize pathogen DNA and mediate innate immune response, expressing highly in pan cancerous such as lung cancer, gastric cancer, and liver cancer, which is associated with poor prognosis22.